🇺🇸 OGN — Organon & Co.

Salud Mantener
← Volver

Precio actual

13,83 USD

Máx. histórico

39,36

1708 días

Caída desde máximo

-64,86%

Rango 52 semanas

5,69 – 13,87

Variación hoy

-0,14%

Cierre anterior

13,85

Rango de hoy

13,83 – 13,87

Volumen hoy

2.172.358

Peor caída histórica

-82,69%

02/03/2022 → 30/03/2026

Aún sin recuperar

Volatilidad anualizada ⓘ

46,95%

Información
Nombre completo
Organon & Co.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Drug Manufacturers - General
Empleados
10.000
PER ⓘ
17,73 (puede no estar actualizado)
Dividend yield
0,58% (puede no estar actualizado)
Precio objetivo analistas
10,33 USD (puede no estar actualizado)
Primera cotización
14/05/2021
Precio actualizado
hace 12 horas
Sobre la empresa

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally. The company's women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, Marvelon, and Mercilon to prevent pregnancy; Follistim AQ, which is used to promote development of ovarian follicles; Elonva, a follicle stimulant; Ganirelix acetate injection, an injectable antagonist; Jada for abnormal postpartum uterine bleeding and hemorrhage; and Xaciato for bacterial vaginosis. Its biosimilars portfolio consists of immunology products, such as Brenzys, Renflexis, and Hadlima; oncology products, including Ontruzant and Aybintio; Bildyos and Bilprevda, a recombinant anti-RANKL human monoclonal antibodies; and Poherdy, a neu receptor antagonist. The company also offers cholesterol-modifying medicines under the Zetia, Ezetrol, Vytorin, Inegy, Atozet, Rosuzet, and Zocor brands; Cozaar and Hyzaar for hypertension; respiratory products to control and prevent asthma symptoms under the Singulair, Dulera, Zenhale, and Asmanex brands, as well as seasonal allergic rhinitis under the Nasonex, Clarinex, and Aerius brands. In addition, it provides dermatology products under the Vtama, Diprosone, and Elocon brand; bone health products under the Fosamax brand; and non-opioid pain management products under the Arcoxia, Diprospan, and Celestone brands, as well as Proscar for symptomatic benign prostatic hyperplasia; and Propecia for male pattern hair loss. The company serves drug wholesalers and retailers, hospitals, clinics, government agencies, health maintenance organizations, pharmacy benefit managers, and other institutions. Organon & Co. was founded in 1923 and is headquartered in Jersey City, New Jersey.

Dividendos repartidos Total últimos 12 meses: 0,0800 USD · Yield: 0,58%
Fecha de pago Importe por participación
14/08/2026 0,0200 USD
11/05/2026 0,0200 USD
23/02/2026 0,0200 USD
20/11/2025 0,0200 USD
15/08/2025 0,0200 USD
12/05/2025 0,0200 USD
24/02/2025 0,2800 USD
12/11/2024 0,2800 USD
16/08/2024 0,2800 USD
10/05/2024 0,2800 USD
23/02/2024 0,2800 USD
10/11/2023 0,2800 USD
17/08/2023 0,2800 USD
12/05/2023 0,2800 USD
24/02/2023 0,2800 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/10/2021 36,70 36,70 35,52 35,72 -2,70% 3,23% 1.013.500
26/10/2021 36,78 37,34 36,50 36,71 -0,54% 2,28% 1.598.500
25/10/2021 35,49 36,96 35,41 36,91 +3,51% 4,37% 1.497.900
22/10/2021 35,33 35,79 35,11 35,66 +0,85% 1,92% 765.500
21/10/2021 35,66 35,75 35,13 35,36 -1,12% 1,74% 1.100.500
20/10/2021 35,19 36,22 34,98 35,76 +2,00% 3,52% 1.161.000
19/10/2021 34,83 35,39 34,70 35,06 +0,75% 1,98% 1.246.500
18/10/2021 34,82 35,12 34,46 34,80 -0,26% 1,90% 1.236.200
15/10/2021 33,96 35,25 33,76 34,89 +3,72% 4,39% 1.675.900
14/10/2021 33,15 33,94 33,10 33,64 +1,48% 2,53% 1.624.700
13/10/2021 33,00 33,33 32,66 33,15 +0,94% 2,02% 1.251.100
12/10/2021 33,18 33,54 32,76 32,84 -1,11% 2,35% 1.271.300
11/10/2021 32,58 33,26 32,55 33,21 +1,96% 2,17% 1.319.400
08/10/2021 32,79 32,87 32,22 32,57 -0,82% 1,98% 1.249.000
07/10/2021 32,99 33,32 32,74 32,84 -0,70% 1,76% 1.339.600
06/10/2021 32,23 33,14 31,92 33,07 +1,66% 3,79% 2.533.300
05/10/2021 32,68 33,14 32,49 32,53 -1,24% 1,99% 2.452.800
04/10/2021 33,18 33,58 32,82 32,94 -1,17% 2,29% 1.784.800
01/10/2021 32,88 33,60 32,56 33,33 +1,65% 3,16% 1.497.500
30/09/2021 33,93 34,17 32,78 32,79 -3,50% 4,10% 1.481.600
29/09/2021 33,02 34,00 33,01 33,98 +2,85% 3,00% 1.306.300
28/09/2021 33,50 33,52 32,90 33,04 -1,49% 1,87% 1.286.800
27/09/2021 33,69 33,87 33,42 33,54 -0,45% 1,34% 1.281.300
24/09/2021 33,50 33,95 33,00 33,69 +0,93% 2,84% 1.888.100
23/09/2021 32,76 33,47 32,68 33,38 +2,24% 2,41% 1.608.400
22/09/2021 33,09 33,24 32,59 32,65 -0,73% 1,96% 1.332.100
21/09/2021 33,19 33,39 32,75 32,89 -0,15% 1,93% 1.162.900
20/09/2021 33,24 33,70 32,77 32,94 -3,20% 2,80% 1.937.300
17/09/2021 33,70 34,08 33,26 34,03 +0,80% 2,43% 4.341.400
16/09/2021 33,89 34,09 33,02 33,76 +0,12% 3,16% 1.280.600